🇺🇸 FDA
Pipeline program

ALX2004

ALX2004-01

Phase 1 small_molecule active

Quick answer

ALX2004 for NSCLC (Advanced Non-small Cell Lung Cancer) is a Phase 1 program (small_molecule) at ALX ONCOLOGY HOLDINGS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ALX ONCOLOGY HOLDINGS INC
Indication
NSCLC (Advanced Non-small Cell Lung Cancer)
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials